
Eylea outperforms other drugs for diabetic macular edema with moderate vision loss
In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when ...
Feb 18, 2015
0
38